Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

10.0%

2 terminated/withdrawn out of 20 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

20%

4 trials in Phase 3/4

Results Transparency

50%

8 of 16 completed trials have results

Key Signals

8 with results

Enrollment Performance

Analytics

Phase 1
6(31.6%)
N/A
6(31.6%)
Phase 2
3(15.8%)
Phase 4
2(10.5%)
Phase 3
2(10.5%)
19Total
Phase 1(6)
N/A(6)
Phase 2(3)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT06119750Not ApplicableCompleted

4-Day Primary Irritation Patch Test of MIS Solution

Role: collaborator

NCT05447546Phase 1Completed

Study to Evaluate HT-6184 in Healthy Subjects

Role: collaborator

NCT00987545Phase 2Terminated

Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence

Role: collaborator

NCT02062073Phase 1Completed

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

Role: collaborator

NCT03472534Phase 1Completed

A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% Ointment

Role: collaborator

NCT03575780Phase 1Completed

Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis

Role: collaborator

NCT02403999Not ApplicableCompleted

A Tolerability Assessment Study of Three Wash Products in Infants

Role: collaborator

NCT02635698Not ApplicableCompleted

Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight

Role: collaborator

NCT02787356Not ApplicableWithdrawn

Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging

Role: collaborator

NCT01030653Phase 4Completed

Pharmacokinetics of Voriconazole in Obese Subjects

Role: collaborator

NCT02587819Phase 1Completed

Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment

Role: collaborator

NCT00917306Phase 3Completed

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

Role: collaborator

NCT00953732Completed

A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies

Role: collaborator

NCT01172522Phase 2Completed

Topical Treatment of Under Eye Dark Circles and Swelling

Role: collaborator

NCT01574612Phase 3Completed

Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

Role: collaborator

NCT02080780Phase 1Completed

Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects

Role: collaborator

NCT01686295Not ApplicableUnknown

24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness

Role: collaborator

NCT00762476Phase 2Completed

Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses

Role: collaborator

NCT01492140Phase 4Unknown

Injection Assistance Device Versus Manual Injections for Delivery of Dermal Fillers

Role: lead

NCT01014832Not ApplicableCompleted

Efficacy and Safety of Frequently Modified Intensive Insulin

Role: collaborator

All 20 trials loaded